Index of /wp-content/uploads/2021/05/
| Name | Last Modified | Size |
|---|---|---|
 Parent Directory | ||
 Final_Plain-English-Summary-Nivolumab-plus-Ipilimumab-21018.pdf | 2023-03-09 11:31 | 148k |
| Final_Technical-Summary-Nivolumab-plus-Ipilimumab-21018.pdf | 2023-03-09 11:31 | 696k |
![[IMG]](/wp-content/uploads/2021/05/Headshot-150x150.jpg) Headshot-150x150.jpg | 2023-03-09 11:31 | 8k |
![[IMG]](/wp-content/uploads/2021/05/Headshot.jpg) Headshot.jpg | 2023-03-09 11:31 | 8k |
| Plain-English-Summary-Pembrolizumab-19051.pdf | 2023-03-09 11:31 | 180k |
| Plain-English-Summary-Romosozumab-21016.pdf | 2023-03-09 11:31 | 320k |
| Plain-English-Summary1-1-1.pdf | 2023-03-09 11:31 | 296k |
| Plain-English-Summary1-1.pdf | 2023-03-09 11:31 | 296k |
| Plain-English-Summary1.pdf | 2023-03-09 11:31 | 296k |
| Technical-Summary-19051-Pembrolizumab-3-1.pdf | 2023-03-09 11:31 | 248k |
| Technical-Summary-19051-Pembrolizumab-3.pdf | 2023-03-09 11:31 | 248k |
| Technical-summary-romosozumab-Evenity-21016.pdf | 2023-03-09 11:31 | 756k |